![logo_lg](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_uZJei21jo1FUYOpnb20Fuz_WpEyCFi60YjG1flks4yZ4JEF8FkfwJy17DTwPKxc9ZWjBunM0Egs77iXJ1ALMsJJJW71o0TVOe1V4cPWBH70vTiohz1t57olsP1591uk77Dj9Lu-kVwYp-yYEhawpNQZ7cP=s0-d)
In August 2011, Intersect won approval from the FDA for
Propel, which, simply put, is a stent that doctors implant in the sinuses after surgery to help keep them open. The cool part is that, over time, the stent absorbs into the patient's body post-surgery (so that follow-up surgery isn't required), slowly releasing a steroid to help control local inflammation,
according to Medgadget. In the fall of last year, the company won approval again for the Propel Mini, a miniaturized version of its flagship product designed for "less extensive surgeries," Medgadget says.
Source: http://feedproxy.google.com/~r/Techcrunch/~3/MOWvOOQwBkY/
davy jones deep impact miesha tate vs ronda rousey idiocracy usssa baseball alex o loughlin the godfather
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন